Range Advisory, LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.12M Buy
2,597
+1,078
+71% +$1.1M 0.37% 50
2026
Q1
$1.4M Buy
1,519
+97
+7% +$98.3K 0.26% 61
2025
Q4
$1.53M Buy
+1,422
New +$1.36M 0.39% 45

Other funds holding LLY

Range Advisory, LLC's LLY Position: Q2 2026 in Review

Range Advisory, LLC increased its Eli Lilly (LLY) stake by 71% in Q2 2026, buying an estimated $1.1M and bringing the position to 2,597 shares worth $3.12M. The position accounts for 0.37% of the portfolio, ranked #50.

Range Advisory, LLC first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Range Advisory, LLC held 2,597 shares of Eli Lilly worth $3.12M as of Q2 2026.
  • Range Advisory, LLC bought 1,078 Eli Lilly shares in Q2 2026, an estimated $1.1M.
  • Eli Lilly made up 0.37% of Range Advisory, LLC's portfolio in Q2 2026, its #50 holding.
  • Range Advisory, LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Range Advisory, LLC's 13F filing for Q2 2026, filed 2 Sep 2026.